Validity and Reliability of the Turkish Translation of the Yale Pharyngeal Residue Severity Rating Scale

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-15

Study Completion Date

2020-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose of the study is the validity and reliability of the Turkish version of the Yale Pharyngeal Residue Severity Rating Scale (YPRSRS-T), so that it would be used as an assessment tool for dysphagia patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The swallow function is a multidirectional process that depends on complex neuro-muscular network. The function can be evaluated using instrumental, such as fibreoptic endoscopic evaluation of swallowing (FEES), videofluoroscopy, or well structured scales. There are many questionnaire and scales for assessment of swallow but very few have been validated. The study will assess the construct validity and reliability of the Turkish version of Pharyngeal Residue Severity Rating Scale as known as Yale Pharyngeal Residue Severity Rating Scale.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Swallowing Disorder Validation Pharyngeal Dysphagia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Pharyngeal residue swallow scale Yale

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Twelve health professionals randomised assign to as equally count. The participants match between the images with scale scores. After 2 weeks, the participants match again.

No interventions assigned to this group

Group B

Twelve health professionals randomised assign to as equally count. The participants match between the images with scale scores.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-70 years
* at least having undergraduate education on health profession
* agree to participant

Exclusion Criteria

* out of age 18-70 years
* out of having undergraduate education
* mental disorder
* cognitive limitations
* visual limitations

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yavuz Atar

Associate Professor, M.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Melis Ece Arkan Ararat, MD

Role: PRINCIPAL_INVESTIGATOR

University of Health Sciences, Prof Dr Cemil Tascioglu City Hospital

Ugur Uygan, MD

Role: PRINCIPAL_INVESTIGATOR

University of Health Sciences, Prof Dr Cemil Tascioglu City Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Prof Dr Cemil Tascioglu City Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

308

Identifier Type: -

Identifier Source: org_study_id